NBIX- Neurocrine Biosciences, Inc.

Insider activity in NBIX over the last quarter tilts toward selling: insiders offloaded a net 6,541 shares worth roughly $1.1M.

Classified under Pharmaceuticals (Health Care sector), NBIX's insider flows are most useful compared with peers in the same group.

Insider Ownership

Role	Insider	Shares	Value	30d
Dir	Gorman Kevin Charles	517.8K	$80.89M	-
CEO	Gano Kyle	154.7K	$24.17M	-
Other	Benevich Eric	67.3K	$10.51M	-
Other	Lippoldt Darin	56.8K	$8.87M	-
CFO	Abernethy Matt	42.8K	$6.73M	-

Buys and sells only

10 filings · page 2

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jun 2, 2026	Cooke Julie59	Chief Human Resources Officer	Sale+OE	36,937	$156.22	$5,770,235.26	-62.3%	-	-
Jun 1, 2026	Onyia Jude51	Chief Scientific Officer	Sale+OE	11,000	$160.25	$1,762,710.40	-29.9%	-	-
May 29, 2026	Delaet Ingrid66	Chief Regulatory Officer	Sale+OE	2,261	$156.71	$354,321.31	-12.2%	-	-
May 27, 2026	Onyia Jude51	Chief Scientific Officer	Sale+OE	11,000	$155.53	$1,710,865.20	-29.9%	-	-
May 26, 2026	Boyer David W.51	Chief Corp. Affairs Officer	Sell	3,888	$156.64	$609,023.32	-33.3%	-	-
May 19, 2026	Gorman Kevin Charles55	Director	Sale+OE	245,088	$154.33	$37,824,872.20	-32.4%	-	-
May 15, 2026	Pops Richard F57	Director	Sale+OE	15,000	$157.65	$2,364,760.50	-30.3%	-	-
May 12, 2026	Norwalk Leslie V64	Director	Sell	3,810	$155.01	$590,601.05	-61.1%	-	-
Jan 16, 2026	Gano Kyle54	Chief Executive Officer	Sale+OE	36,400	$132.70	$4,830,458.10	-20.6%	-	-
Dec 16, 2025	Norwalk Leslie V64	Director	Sale+OE	6,190	$152.78	$945,701.91	-49.8%	-12.7%	-